Skip to main content
A

AlphaLit

This litigation finance origination platform filters prospective plaintiffs and assigns them to attorneys, creating asset-backed securities from filed cases. These securities are then sold to litigation funders, providing investors with diversified and de-risked litigation assets.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Individual plaintiffs often lack the resources to pursue meritorious legal claims, while attorneys face challenges in securing high-quality cases ready for litigation. Litigation funders seek diversified portfolios of cases to mitigate risk and generate returns, but sourcing and assessing these cases can be inefficient.

Solution

AlphaLit is a litigation finance asset formation platform that connects plaintiffs with attorneys and provides litigation funders with diversified portfolios of pre-vetted cases. The platform identifies high-value prospective plaintiffs and develops their claims, then uses a proprietary 17-point rubric to assess case quality. AlphaLit completes initial intake and develops legal strategies before connecting plaintiffs with partner attorneys experienced in relevant practice areas. Finally, AlphaLit provides cross-collateralized portfolios of filed cases to litigation funders, offering diversified, low-risk litigation assets.

Target Audience

AlphaLit serves individual plaintiffs seeking legal representation and funding, attorneys looking for vetted cases ready for litigation, and litigation funders seeking diversified, high-yield case portfolios.

Features

  • Proprietary 17-point rubric for identifying high-value claims
  • Multi-channel marketing and lead qualification to source plaintiffs at scale
  • Initial legal strategy development and case packaging for attorneys
  • Vetted plaintiffs and completed intake process
  • Cross-collateralized portfolios of recently filed cases
  • Focus on single-plaintiff claims to minimize duration and appellate risk
This profile is AI-generated and may contain inaccuracies.